Subscribe
Subscribe & Save!
Subscribe now and save 50% off the cover price of the Indianapolis Monthly magazine.
×

Lilly

Read More

Inside Eli Lilly’s Race For A Coronavirus Therapy

What we know about the world’s first potential antibody treatment designed to fight COVID-19.

Read More

Lilly Eyes 2021 For Return To Full Strength

The pharmaceutical giant’s plan is more cautious than that of Governor Holcomb.

Read More

Mike Dalton, Eli Lilly Chemist

At the pharmaceutical giant, Dalton’s job is to thwart counterfeiters, who can be a real pill.

default featured image
Read More

Change the City: Get the Grant

Ready to bite the bullet and go after that check? Catherine Parker of Parker Grant Solutions has some tips for acing the application.

Read More

The Unblinding: Has Lilly Solved The Alzheimer’s Puzzle?

Eli Lilly and Company has spent three decades and $3 billion in an Ahab-like quest to develop the world’s first effective drug to treat Alzheimer’s disease.

default featured image
Read More

Life after Zyprexa: the Future of Eli Lilly and Company

“We want high quality of life as long as possible, don’t we?” says Lilly executive Jan Lundberg. “Many of our current diseases are chronic, and they accumulate with age, so there are major demands coming from the aging population.”

Zyprexa
Read More

Side Effects

With thousands of medical success stories and billions in revenue, officials at Lilly are still celebrating the success of Zyprexa. But its troubled path reveals volumes about how difficult bringing even an approved medication to market can turn out to be.

X
X